1-4 of 4
Roderick L. Beijersbergen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB_A19: Genome-wide CRISPR/Cas9 screens for the identification of targeted vulnerabilties in PARP inhibitor-resistant PARG;BRCA2-deficient tumor cells: A focus on EXO1/FEN1-mediated DNA repair

Christina Andronikou, Kamila Burdova, Diego Dibitetto, Cor Lieftink, Roderick L. Beijersbergen, Hana Hanzlikova, Jos Jonkers, Sven Rottenberg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): LB_A19.
https://doi.org/10.1158/1535-7163.TARG-23-LB_A19
Published: 01 December 2023
View article titled, Abstract LB_A19: Genome-wide CRISPR/Cas9 screens for the identification of targeted vulnerabilties in PARP inhibitor-resistant PARG;BRCA2-deficient tumor cells: A focus on EXO1/FEN1-mediated DNA repair
Journal Articles

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition

Marta Llaurado Fernandez, E. Marielle Hijmans, Annemiek M.C. Gennissen, Nelson K.Y. Wong, Shang Li, G. Bea A. Wisman, Aleksandra Hamilton, Joshua Hoenisch, Amy Dawson, Cheng-Han Lee, Madison Bittner, Hannah Kim, Gabriel E. DiMattia, Christianne A.R. Lok, Cor Lieftink, Roderick L. Beijersbergen, Steven de Jong, Mark S. Carey, René Bernards, Katrien Berns
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1862–1874.
https://doi.org/10.1158/1535-7163.MCT-22-0004
Published: 02 December 2022
View article titled, NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
Open the PDF for NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma

Diede Brunen, Romy C. de Vries, Cor Lieftink, Roderick L. Beijersbergen, René Bernards
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (4): 849–857.
https://doi.org/10.1158/1535-7163.MCT-17-0868
Published: 01 April 2018
View article titled, PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma
Open the PDF for PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R

Klaas de Lint, Jos B. Poell, Hayssam Soueidan, Katarzyna Jastrzebski, Jordi Vidal Rodriguez, Cor Lieftink, Lodewyk F.A. Wessels, Roderick L. Beijersbergen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (7): 1545–1556.
https://doi.org/10.1158/1535-7163.MCT-15-0865
Published: 05 July 2016
View article titled, Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R
Open the PDF for Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R in another window
Includes: Supplementary data